Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

DEGs in the bone marrow of Esr1Nkx2-1Cre females

ABSTRACT: DEGs in the bone marrow of Esr1Nkx2-1Cre females

PROVIDER: PRJNA503331 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8144240.fastq.gz	Fastqsanger.gz
	SRR8144241.fastq.gz	Fastqsanger.gz
	SRR8144242.fastq.gz	Fastqsanger.gz
	SRR8144243.fastq.gz	Fastqsanger.gz
	SRR8144244.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

DEGs in the bone marrow of Esr1Nkx2-1Cre females

Project description:Disrupting central estrogen signaling exposes a powerful sex-dependent brain-to-bone axis in female mice triggering massive increases in bone density.

2018-11-02 | GSE122055 | GEO

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Project description:RATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of bone marrow transplantation in treating patients who have hematologic cancer.

| 2004880 | ecrin-mdr-crc

Bone marrow niche

Project description:Bone marrow niche

| PRJNA429031 | ENA

Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer

Project description:This phase II trial studies how well giving fludarabine phosphate, cyclophosphamide, tacrolimus, mycophenolate mofetil and total-body irradiation together with a donor bone marrow transplant works in treating patients with high-risk hematologic cancer. Giving low doses of chemotherapy, such as fludarabine phosphate and cyclophosphamide, and total-body irradiation before a donor bone marrow transplant helps stop the growth of cancer cells by stopping them from dividing or killing them. Giving cyclophosphamide after transplant may also stop the patient’s immune system from rejecting the donor’s bone marrow stem cells. The donated stem cells may replace the patient’s immune system cells and help destroy any remaining cancer cells (graft-versus-tumor effect). Sometimes the transplanted cells from a donor can also make an immune response against the body’s normal cells. Giving tacrolimus and mycophenolate mofetil after the transplant may stop this from happening

| 2008483 | ecrin-mdr-crc

bone marrow metagenome

Project description:Rashidi - 7D Bone Marrow

| PRJNA698990 | ENA

RNA-seq of CD11bhiLy6ChiLy6Glo bone marrow cells and CD11bmidLy6CmidLy6Glo bone marrow cells against CD11bloLy6CloLy6Glo bone marrow cells

Project description:RNA-seq of CD11bhiLy6ChiLy6Glo bone marrow cells and CD11bmidLy6CmidLy6Glo bone marrow cells against CD11bloLy6CloLy6Glo bone marrow cells

| PRJEB37925 | ENA

Bone Marrow - scRNA-sequencing

Project description:Bone Marrow - scRNA-sequencing

| PRJNA790965 | ENA

Mouse bone marrow inDrop

Project description:Mouse bone marrow inDrop

| PRJNA432520 | ENA

Bone marrow mononuclear cells

Project description:Bone marrow mononuclear cells

| PRJNA801122 | ENA